POSC284 The Acceptance of Minimal Residual Disease (MRD) as a Clinical Endpoint in Multiple Myeloma (MM): A Targeted Literature Review
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.921
https://www.valueinhealthjournal.com/article/S1098-3015(21)02716-9/fulltext
Title :
POSC284 The Acceptance of Minimal Residual Disease (MRD) as a Clinical Endpoint in Multiple Myeloma (MM): A Targeted Literature Review
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02716-9&doi=10.1016/j.jval.2021.11.921
First page :
Section Title :
Open access? :
No
Section Order :
10450